Arrowhead Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is October - September.

Millions USD. Fiscal year is Oct - Sep.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021
Revenue	829.45	3.55	240.74	243.23	138.29
Revenue Growth (YoY)	23258.15%	-98.52%	-1.03%	75.89%	57.16%
Gross Profit	829.45	3.55	240.74	243.23	138.29
Selling, General & Admin	138.5	113.44	104.08	132.44	85.44
Research & Development	592.6	491.19	341.66	289.3	201.88
Operating Expenses	731.1	604.63	445.74	421.74	287.32
Operating Income	98.35	-601.08	-205	-178.51	-149.04
Interest Expense	-89.36	-32.35	-18.33	-	-
Interest & Investment Income	37.29	22.72	15.3	5.03	6.12
Other Non Operating Income (Expenses)	5.26	-1.75	1.54	0.77	2.07
EBT Excluding Unusual Items	51.53	-612.46	-206.49	-172.71	-140.85
Pretax Income	51.53	-612.46	-206.49	-172.71	-140.85
Income Tax Expense	21.42	-2.77	2.78	3.79	0
Earnings From Continuing Operations	30.11	-609.69	-209.28	-176.49	-140.85
Minority Interest in Earnings	-31.75	10.2	4	0.43	-
Net Income	-1.63	-599.49	-205.28	-176.06	-140.85
Net Income to Common	-1.63	-599.49	-205.28	-176.06	-140.85
Shares Outstanding (Basic)	134	120	107	105	104
Shares Outstanding (Diluted)	134	120	107	105	104
Shares Change (YoY)	11.67%	12.21%	1.26%	1.62%	3.00%
EPS (Basic)	-0.01	-5.00	-1.92	-1.67	-1.36
EPS (Diluted)	-0.01	-5.00	-1.92	-1.67	-1.36
Free Cash Flow	156.89	-604.32	-330.63	-188.91	147.75
Free Cash Flow Per Share	1.17	-5.04	-3.10	-1.79	1.42
Gross Margin	100.00%	100.00%	100.00%	100.00%	100.00%
Operating Margin	11.86%	-16927.06%	-85.16%	-73.39%	-107.77%
Profit Margin	-0.20%	-16882.37%	-85.27%	-72.39%	-101.85%
Free Cash Flow Margin	18.92%	-17018.31%	-137.34%	-77.67%	106.84%
EBITDA	122.27	-582.49	-192.51	-168.09	-140.77
EBITDA Margin	14.74%	-	-79.97%	-69.11%	-101.79%
D&A For EBITDA	23.93	18.6	12.49	10.42	8.27
EBIT	98.35	-601.08	-205	-178.51	-149.04
EBIT Margin	11.86%	-	-85.16%	-73.39%	-107.77%
Effective Tax Rate	41.56%	-	-	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.